SynthesisBreast (Edinburgh, Scotland)2021

Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe.

L Moscetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.